Al-Rowaili A, Al-aqeel S A, Al-Naim L S, Al-Diab A I
Clinical Pharmacy Department, King Saud University, Kingdom of Saudi Arabia.
Gulf J Oncolog. 2009 Jan(5):37-43.
The aim of the study was to assess the appropriateness of pain management in cancer patients by determining the modalities of pain treatment currently provided to cancer patients, comparing this treatment to existing guideline on control of pain in patients with cancer and identifying areas of inappropriate prescribing. A prospective observational study was carried out in the oncology unit at tertiary-care teaching hospital in Riyadh, Saudi Arabia over a period from May-October 2006 included all adult cancer patients. Of 160 patients participated in the study, 80 (50%) reported moderate or severe pain. 40% of those with pain were not given any pain medication. Sixty percent of the patients had appropriate pain management. Pain documentation was inappropriate and needs improvement in 57% of the patients. There was under utilization of NSAIDs which were prescribed in 8 (5%) patients only from those on pain medication. Transdermal fentanyl was the most frequently used opioid (21%) for moderate to severe pain. Therefore, despite published guidelines for pain management, many patients with cancer receive inadequate analgesia.
该研究的目的是通过确定目前为癌症患者提供的疼痛治疗方式、将这种治疗与现有的癌症患者疼痛控制指南进行比较以及找出不适当处方的领域,来评估癌症患者疼痛管理的适宜性。2006年5月至10月期间,在沙特阿拉伯利雅得的一家三级护理教学医院的肿瘤科进行了一项前瞻性观察研究,纳入了所有成年癌症患者。在参与研究的160名患者中,80名(50%)报告有中度或重度疼痛。40%的疼痛患者未接受任何止痛药物治疗。60%的患者有适当的疼痛管理。57%的患者疼痛记录不适当,需要改进。非甾体抗炎药使用不足,仅8名(5%)接受止痛药物治疗的患者使用了该药物。透皮芬太尼是用于中度至重度疼痛最常用的阿片类药物(21%)。因此,尽管有已发表的疼痛管理指南,但许多癌症患者仍未得到充分的镇痛治疗。